The FDA’s traditional approval of Leqembi marks the first-ever approval of a disease-modifying therapy for Alzheimer’s, signifying the dawn of a new era in Alzheimer’s treatment With clarity on the modest clinical benefit of anti-amyloids, the time is now for the Alzheimer’s field to…